<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: Asymmetric dimethylarginine (ADMA), <z:chebi fb="0" ids="25682">symmetric dimethylarginine</z:chebi> (SDMA), and l-arginine directly influence nitric <z:chebi fb="177" ids="25741,29356">oxide</z:chebi> production </plain></SENT>
<SENT sid="1" pm="."><plain>Our objective was to test whether serum ADMA, SDMA, or l-arginine levels correlate with diabetic <z:hpo ids='HP_0000488'>retinopathy</z:hpo> subtype or severity </plain></SENT>
<SENT sid="2" pm="."><plain>RESEARCH DESIGN AND METHODS: A total of 162 subjects with type 1 <z:mp ids='MP_0002055'>diabetes</z:mp> and 343 with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp>, of whom 329 subjects had no diabetic <z:hpo ids='HP_0000488'>retinopathy</z:hpo>, 27 had nonproliferative diabetic <z:hpo ids='HP_0000488'>retinopathy</z:hpo> (NPDR), 101 had proliferative diabetic <z:hpo ids='HP_0000488'>retinopathy</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PDR</z:e>), and 107 had clinically significant macular <z:hpo ids='HP_0000969'>edema</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CSME</z:e>), were recruited </plain></SENT>
<SENT sid="3" pm="."><plain>Blinding diabetic <z:hpo ids='HP_0000488'>retinopathy</z:hpo> was defined as <z:e sem="disease" ids="C0730278" disease_type="Disease or Syndrome" abbrv="">severe NPDR</z:e>, <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PDR</z:e>, or <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CSME</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>Serum ADMA, SDMA, and l-arginine concentrations were determined by mass spectroscopy </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: In multivariate analysis, blinding diabetic <z:hpo ids='HP_0000488'>retinopathy</z:hpo>, <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PDR</z:e>, and <z:hpo ids='HP_0000112'>nephropathy</z:hpo> were associated with significantly increased serum levels of ADMA (P &lt; 0.001), SDMA (P &lt; 0.001), and l-arginine (P = 0.001) </plain></SENT>
<SENT sid="6" pm="."><plain>Elevated ADMA (P &lt; 0.001) and SDMA (P &lt; 0.001) were also significantly associated with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CSME</z:e> </plain></SENT>
<SENT sid="7" pm="."><plain>CONCLUSIONS: Severe forms of diabetic <z:hpo ids='HP_0000488'>retinopathy</z:hpo> are associated with elevated serum ADMA, SDMA, and l-arginine </plain></SENT>
<SENT sid="8" pm="."><plain>Further investigation is required to determine whether these findings are of clinical relevance </plain></SENT>
</text></document>